Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?
Jamile AbudBruna Brasil Dal PupoCynthia Keitel da SilvaElizete KeitelValter Duro GarciaRoberto Ceratti ManfroJorge NeumannPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2021)
The results showed that discontinuing the AHG-CDCXM assay does not modify the clinical outcomes in a 1-year follow-up.
Keyphrases